Where Smart Money Looks Next
Complimentary AI-assisted portfolio analysis and curated stock picks — helping investors discover high-potential opportunities in the public markets.
The Stock Sleuth
"Do the math..."Complimentary AI-assisted portfolio analysis and curated stock picks — helping investors discover high-potential opportunities in the public markets.
The Stock Sleuth
"Do the math..."NASDAQ: CMPS
Compass Pathways is arguably one of the most advanced psychedelic-medicine companies in the world.
Wall Street's six covering analysts have a mean target of $24.83 (median $16.50), implying roughly 77–167% upside on CMPS, with H.C. Wainwright's outlier high of $70 implying ~7x.
Share Price
~$9.30
Market Cap
~$1.25B
Sector
Psychedelic Medicine
Why Choose Us
Since 2012 when we published the first Wall Street Profit Search to spotlight the launch of the first Gold Bullion ATM, our Profiled Companies and Other Situations have consistently highlighted high-potential opportunities across multiple sectors.
Our decades of capital markets work includes major organic media coverage for some of our Profiled Companies on CNN, CNBC, Fox Business and other media outlets, as well as relationships with Institutional Investors.
Read our disclosures. Every "Profiled Company" goes through a compliance review and fact-checking before it reaches you. We work with a securities attorney to ensure accuracy and transparency.
Latest Insights
Market analysis, trading insights, and deep dives into the companies and sectors that matter.